Nano-ablative immunotherapy for cancer treatment
Immunotherapy has provided a new avenue to treat metastatic cancers, which result in ∼90% of cancer related deaths. However, current immunotherapies, such as immune checkpoint therapy (ICT), have met with limited success, primarily due to tumor intrinsic and extrinsic factors that inhibit antitumor...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-08-01
|
Series: | Nanophotonics |
Subjects: | |
Online Access: | https://doi.org/10.1515/nanoph-2021-0171 |